- Home
- KALA vs IHT Comparison
KALA vs IHT Comparison
Compare KALA & IHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- IHT
- Stock Information
- Founded
- KALA 2009
- IHT 1971
- Country
- KALA United States
- IHT United States
- Employees
- KALA N/A
- IHT N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- IHT Investment Bankers/Brokers/Service
- Sector
- KALA Health Care
- IHT Finance
- Exchange
- KALA Nasdaq
- IHT Nasdaq
- Market Cap
- KALA 27.3M
- IHT 22.2M
- IPO Year
- KALA 2017
- IHT N/A
- Fundamental
- Price
- KALA $6.64
- IHT $2.58
- Analyst Decision
- KALA Strong Buy
- IHT
- Analyst Count
- KALA 2
- IHT 0
- Target Price
- KALA $15.00
- IHT N/A
- AVG Volume (30 Days)
- KALA 108.1K
- IHT 2.3K
- Earning Date
- KALA 03-28-2025
- IHT 04-07-2025
- Dividend Yield
- KALA N/A
- IHT 0.78%
- EPS Growth
- KALA N/A
- IHT N/A
- EPS
- KALA N/A
- IHT N/A
- Revenue
- KALA N/A
- IHT $7,692,305.00
- Revenue This Year
- KALA N/A
- IHT N/A
- Revenue Next Year
- KALA N/A
- IHT N/A
- P/E Ratio
- KALA N/A
- IHT N/A
- Revenue Growth
- KALA N/A
- IHT 4.55
- 52 Week Low
- KALA $4.21
- IHT $1.25
- 52 Week High
- KALA $11.20
- IHT $2.70
- Technical
- Relative Strength Index (RSI)
- KALA 39.29
- IHT 57.81
- Support Level
- KALA $6.50
- IHT $2.53
- Resistance Level
- KALA $8.65
- IHT $2.64
- Average True Range (ATR)
- KALA 0.90
- IHT 0.06
- MACD
- KALA -0.43
- IHT -0.01
- Stochastic Oscillator
- KALA 2.98
- IHT 68.42
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About IHT InnSuites Hospitality Trust Shares of Beneficial Interest
InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns and operates hotels, provides management services for hotels, and also provides trademark license services. The Trust is also involved in various operations incidental to the operation of hotels, such as the operation of restaurants, meeting/banquet room rentals, and the operation of a reservation system. It has one reportable segment Hotel Operations & Hotel Management Services.